Court Report – February 02, 2014
Eli Lilly and Company v. Glenmark Generics Inc., USA 1:14-cv-00104; filed January 23, 2013 in the Southern District of Indiana Infringement of U.S. Patent No.
Eli Lilly and Company v. Glenmark Generics Inc., USA 1:14-cv-00104; filed January 23, 2013 in the Southern District of Indiana Infringement of U.S. Patent No.
Eli Lilly and Company v. Glenmark Generics Inc., USA 1:14-cv-00104; filed January 23, 2013 in the Southern District of Indiana Infringement of U.S. Patent No.Source: www.topix.com Via newsmixx: home News
Despite Asbestos Hurdle, Hinsdale Middle School to Reopen On ScheduleSource: www.mesothelioma.com Via newsmixx: home News
Despite Asbestos Hurdle, Hinsdale Middle School to Reopen On Schedule
Defendants Plead Guilty to Illegally Removing Asbestos from Former Zurbrugg Memorial Hospital SiteSource: www.mesothelioma.com Via newsmixx: home News
Defendants Plead Guilty to Illegally Removing Asbestos from Former Zurbrugg Memorial Hospital Site
A Thorne woman who lost her dad to an asbestos related illness is raising awareness of the silent killer disease.
A Thorne woman who lost her dad to an asbestos related illness is raising awareness of the silent killer disease.Source: www.topix.com Via newsmixx: home News
Research using RNA interference -based screening has identified several potential targets for the treatment of malignant pleural mesothelioma .
Research using RNA interference -based screening has identified several potential targets for the treatment of malignant pleural mesothelioma .Source: www.topix.com Via newsmixx: home News
Two Northern New Yorkers Plead Guilty for Illegal Asbestos Removal and DisposalSource: www.mesothelioma.com Via newsmixx: home News
Two Northern New Yorkers Plead Guilty for Illegal Asbestos Removal and Disposal
Aduro BioTech, Inc., a clinical stage biotechnology company, today announced that the company’s chairman and chief executive officer, Stephen T. Isaacs, will present a company overview at the following upcoming conferences: To access the live webcast a…
Aduro BioTech, Inc., a clinical stage biotechnology company, today announced that the company’s chairman and chief executive officer, Stephen T. Isaacs, will present a company overview at the following upcoming conferences: To access the live webcast a…
CNT may exist as fibres or as more compact particles and the asbestos-type hazard only pertains to the fibrous forms of CNT.”